Form 4: Organogenesis Holdings Inc. Executive Lori Freedman Reports Stock Transaction
SEC Form 4 Filing
Lori Freedman, Chief Admin. and Legal Officer of Organogenesis Holdings Inc., reports the disposition of 1,974 shares of Class A Common Stock to cover tax obligations.
Summary
- On April 1, 2024, Lori Freedman, Chief Admin. and Legal Officer of Organogenesis Holdings Inc., disposed of 1,974 shares of Class A Common Stock.
- The transaction was executed at a price of $2.8 per share.
- Following the transaction, Freedman beneficially owns 469,272 shares of Class A Common Stock directly.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a stock transaction. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor the actions of those with privileged information.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares compared to the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of stock transaction (disposal of shares) |
| 04/03/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.